Applying this criterion (BI = 6.2), the prevalence in the group of healthy subjects and patients with T1DM or T2DM was similar, i.e., 11.3%–12.8% of the samples analyzed were positive for ghrelin-aAb (Figure 4B). The gene discussed is GHRL; the disease is type 1 diabetes mellitus.